Download PDF
Klin Padiatr 2005; 217: 143-149
DOI: 10.1055/s-2005-872508
Therapie von Infektionen in der Kinderonkologie

© Georg Thieme Verlag Stuttgart · New York

Diagnose und Therapie von Infektionen bei Kindern und Jugendlichen mit neoplastischen Erkrankungen - Sonderkapitel Stammzelltransplantation

Infectious Complications in the Child Undergoing Hematopoietic Stem Cell TransplantationF. R. Schuster1 , H.-J. Laws2
  • 1Hämatologisch/Onkologische Abteilung, Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität München
  • 2Klinik für Kinder-Onkologie, -Hämatologie und -Immunologie, Universitätsklinikum Düsseldorf
Further Information

Publication History

Publication Date:
15 November 2005 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Infektionen stellen einen der wichtigsten prognostischen Faktoren für die Überlebenschancen von stammzelltransplantierten Patienten, Kinder und Erwachsenen, dar. Das Auftreten und der Schweregrad der Infektionen sind von der Funktion des Immunsystems im Empfänger abhängig. Die Funktion wird durch den Einsatz immunsuppressiver Medikamente und die Geschwindigkeit der Rekonstitution des Immunsystems nach Transplantation bestimmt. Die Immunrekonstitution kann in die Zeiträume der frühen, mittleren und späten Erholungsphase eingeteilt werden. Die vorliegende Arbeit stellt die Besonderheiten der Infektionsgefährdung innerhalb der jeweiligen Zeiträume nach Stammzelltransplantation (SZT) dar. Die grundlegenden Unterschiede infektiöser Komplikationen sollen zwischen konventionell behandelten bzw. autologen und allogen stammzelltransplantierten onkologischen Patienten im Kindesalter aufgezeigt werden. Hierbei soll neben der Gefährdung in der Aplasie, besonders auf die lang andauernde Immundefizienz nach Transplantation als Risikofaktor für die Entwicklung schwerer Infektionen hingewiesen werden.

Abstract

Infectious complications are a major cause of morbidity and mortality in pediatric and adult patients undergoing hematopoietic stem cell transplantion. The incidence and the severity code of infections depend on the function of the host's immune system. This function is strongly correlated to the application of immune suppressive therapy and the speed of immune reconstitution after stem cell transplantation (SCT). The immune reconstitution can be divided into an early, intermediate and a late phase. This article describes the risk of infections during the different phases of immune reconstitution after stem cell transplantation in children. The basic differences between conventional treated oncologic, autologous and allogenic transplanted children will be presented. Beside the risk in the phase of aplasia there should be pointed out that long term immune deficiency is a strong factor for developing a severe infection after SCT.

Schlüsselwörter

maligne Erkrankungen - Stammzelltransplantation - Infektion - Immunrekonstitution - Kinder

Key words

cancer - stem cell transplantation - infection - immune reconstitution - children

Literatur

  • 1 Bensinger W I, Martin P J, Storer B. et al . Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.  N Engl J Med. 2001;  344 175-181
    CrossrefPubMedGoogle Scholar
  • 2 Bredius R G, Templeton K E, Scheltinga S A. et al . Prospective study of respiratory viral infections in pediatric hemopoietic stem cell transplantation patients.  Pediatr Infect Dis J. 2004;  23 518-522
    PubMedGoogle Scholar
  • 3 Busca A, Saroglia E M, Giacchino M. et al . Analysis of early infectious complications in pediatric patients undergoing bone marrow transplantation.  Support Care Cancer. 1999;  7 253-259
    PubMedGoogle Scholar
  • 4 Center of Disease Control and Prevention . Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.  MMWR Recomm Rep. 2000;  49 1-125
    PubMedGoogle Scholar
  • 5 Dell'Orto M, Rovelli A, Barzaghi A. et al . Febrile complications in the first 100 days after bone marrow transplantation in children: a single center's experience.  Pediatr Hematol Oncol. 1997;  14 335-47
    PubMedGoogle Scholar
  • 6 Einsele H, Bertz H, Beyer J. et al . Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).  Ann Hematol. 2003;  82 (Suppl 2) 175-185
    CrossrefPubMedGoogle Scholar
  • 7 Engelhard D, Elishoov H, Strauss N. et al . Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study.  Transplantation. 1996;  61 430-434
    PubMedGoogle Scholar
  • 8 Groll A H, Ritter J, Muller F M. Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancer.  Klin Padiatr. 2001;  213 (Suppl 1) A38-A49
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Hovi L, Saarinen-Pihkala U M, Vettenranta K. et al . Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.  Bone Marrow Transplant. 2000;  26 999-1004
    CrossrefPubMedGoogle Scholar
  • 10 Ioannidis J P, Cappelleri J C, Skolnik P R. et al . A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.  Arch Intern Med. 1996;  156 177-188
    CrossrefPubMedGoogle Scholar
  • 11 Kalhs P, Panzer S, Kletter K. et al . Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease.  Ann Intern Med. 1988;  109 461-464
    PubMedGoogle Scholar
  • 12 Kauffman C A, Carver P L. Antifungal agents in the 1990s. Current status and future developments.  Drugs. 1997;  53 539-549
    PubMedGoogle Scholar
  • 13 Lehrnbecher T, Varwig D, Kaiser J. et al . Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.  Leukemia. 2004;  18 72-77
    CrossrefPubMedGoogle Scholar
  • 14 Lex C, Korholz D, Kohlmuller B. et al . Infectious complications in children with acute lymphoblastic leukemia and T-cell lymphoma - a rationale for tailored supportive care.  Support Care Cancer. 2001;  9 514-521
    PubMedGoogle Scholar
  • 15 Machatschek J, Duda J, Matthay K. et al . Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children.  Bone Marrow Transplant. 2003;  32 687-693
    CrossrefPubMedGoogle Scholar
  • 16 Maltezou H C, Petropoulos D, Choroszy M. et al . Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation.  Bone Marrow Transplant. 1997;  20 879-881
    CrossrefPubMedGoogle Scholar
  • 17 Meisel R, Enczmann J, Balzer S. et al . Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.  Klin Padiatr. 2005;  217 135-141
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Moss P, Rickinson A. Cellular immunotherapy for viral infection after HSC transplantation.  Nat Rev Immunol. 2005;  5 9-20
    CrossrefPubMedGoogle Scholar
  • 19 Mullen C A, Nair J, Sandesh S. et al . Fever and neutropenia in pediatric hematopoietic stem cell transplant patients.  Bone Marrow Transplant. 2000;  25 59-65
    CrossrefPubMedGoogle Scholar
  • 20 Nagatoshi Y, Kawano Y, Watanabe T. et al . Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population.  Pediatr Transplant. 2002;  6 319-326
    CrossrefPubMedGoogle Scholar
  • 21 Ochs L, Shu X O, Miller J. et al . Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.  Blood. 1995;  86 3979-3986
    PubMedGoogle Scholar
  • 22 Ogden A K, Steuber C P, Mahoney D H. et al . Bone marrow transplantation in childhood leukemia using reverse isolation techniques.  Med Pediatr Oncol. 1990;  18 1-5
    PubMedGoogle Scholar
  • 23 Parkman R, Weinberg K I. Immune Reconstitution following Hematopoietic Cell Transplantation. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Stem Cell Transplantation. 3rd ed. Blackwell Publishing. Malden, Massachusetts 2004; 853-861
    Google Scholar
  • 24 Reddy P, Ferrara J L. Immunobiology of acute graft-versus-host disease.  Blood Rev. 2003;  17 187-194
    CrossrefPubMedGoogle Scholar
  • 25 Romano V, Castagnola E, Dallorso S. et al . Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.  Bone Marrow Transplant. 1999;  23 271-275
    CrossrefPubMedGoogle Scholar
  • 26 Rubinstein P, Stevens C E. Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results.  Baillieres Best Pract Res Clin Haematol. 2000;  13 565-584
    PubMedGoogle Scholar
  • 27 Saral R, Burns W H, Laskin O L. et al . Acyclovir prophylaxis of herpes-simplex-virus infections.  N Engl J Med. 1981;  305 63-67
    PubMedGoogle Scholar
  • 28 Schonberger S, Niehues T, Meisel R. et al . Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.  Klin Padiatr. 2004;  216 356-363
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Schuster F, Moelter C, Schmid I. et al . Successful antifungal combination therapy with voriconazole and caspofungin.  Pediatr Blood Cancer. 2005;  44 682-685
    CrossrefPubMedGoogle Scholar
  • 30 Sullivan K M. Graft versus Host Disease. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Stem Cell Transplantation. 3rd ed. Blackwell Publishing. Malden, Massachusetts 2004; 635-664
    Google Scholar
  • 31 Tuan I Z, Dennison D, Weisdorf D J. Pneumocystis carinii pneumonitis following bone marrow transplantation.  Bone Marrow Transplant. 1992;  10 267-272
    PubMedGoogle Scholar
  • 32 Vicent M G, Madero L, Chamorro L. et al . Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.  Haematologica. 2001;  86 1087-1094
    PubMedGoogle Scholar
  • 33 Viscoli C, Castagnola E, Moroni C. et al . Early infectious complications in children undergoing BMT.  Bone Marrow Transplant. 1991;  7 (Suppl 3) 42-47
    PubMedGoogle Scholar
  • 34 Walter E A, Bowden R A. Infection in the bone marrow transplant recipient.  Infect Dis Clin North Am. 1995;  9 823-847
    PubMedGoogle Scholar
  • 35 Wawer A, Laws H J, Dilloo D. et al . Long-time survival after unrelated bone marrow transplantation in children and adolescents and targeted therapy with CD25 blockade to prevent GVHD.  Klin Padiatr. 2004;  216 169-175
    PubMedGoogle Scholar
  • 36 Whimbey E, Champlin R E, Couch R B. et al . Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.  Clin Infect Dis. 1996;  22 778-782
    CrossrefPubMedGoogle Scholar
  • 37 Wingard J R. Bacterial Infections. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Stem Cell Transplantation. 3rd ed. Blackwell Publishing. Malden, Massachusetts 2004; 665-682
    Google Scholar
  • 38 Zaia J A, Sissons J G, Riddell S. et al .Status of Cytomegalovirus prevention and treatment in 2000. Hematology (Am Soc Hematol Educ Program) 2000: 339-355
    Google Scholar

Dr. med. Friedhelm R. Schuster

Abteilung pädiatrische Onkologie und Hämatologie · Kinderklinik und Kinderpoliklinik im Dr. von Haunerschen Kinderspital der Ludwig-Maximilians-Universität München

Lindwurmstr. 4

80337 München

Email: Friedhelm.Schuster@med.uni-muenchen.de